Basis: Current FMP quote-based enterprise value / matching reported total assets. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/Assets ratio is N/A as of 2026-10-06T17:05:42.784Z.
Calculation as of: 2026-10-06T17:05:42.784Z.
Quote observation: 2026-10-06T17:05:15.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 0fde8dae4c5ae63ee7b35c7e6e46bba2fdf5d6d5db310b32cf0eb41a7e17e840
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/ASSETS RATIO
N/A
Market Cap
$777.83M
EV/Assets Ratio
1.84x
TTM Avg
2.45x
3Y Avg
1.94x
5Y Avg
1.67x
Market Cap
$789.07M
EV/Assets Ratio
1.63x
TTM Avg
1.89x
3Y Avg
3.13x
5Y Avg
3.21x
Market Cap
$789.34M
EV/Assets Ratio
3.76x
TTM Avg
4.08x
3Y Avg
19.79x
5Y Avg
15.81x
Market Cap
$772.90M
EV/Assets Ratio
3.16x
TTM Avg
3.08x
3Y Avg
1.98x
5Y Avg
2.19x
Market Cap
$796.08M
EV/Assets Ratio
0.65x
TTM Avg
0.73x
3Y Avg
0.74x
5Y Avg
0.80x
Market Cap
$764.84M
EV/Assets Ratio
5.74x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$763.75M
EV/Assets Ratio
1.99x
TTM Avg
1.56x
3Y Avg
1.53x
5Y Avg
1.63x
| NAME | MARKET CAP | EV/ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Apnimed, Inc. (APMD) | $781.33M | N/A | N/A | N/A | N/A |
| Sana Biotechnology, Inc. (SANA)vs › | $777.83M | 1.84x | 2.45x | 1.94x | 1.67x |
| Geron Corporation (GERN)vs › | $789.07M | 1.63x | 1.89x | 3.13x | 3.21x |
| Gyre Therapeutics, Inc. (GYRE)vs › | $789.34M | 3.76x | 4.08x | 19.79x | 15.81x |
| Lexicon Pharmaceuticals, Inc. (LXRX)vs › | $772.90M | 3.16x | 3.08x | 1.98x | 2.19x |
| AdaptHealth Corp. (AHCO)vs › | $796.08M | 0.65x | 0.73x | 0.74x | 0.80x |
| Attovia Therapeutics, Inc. (ATTO)vs › | $764.84M | 5.74x | N/A | N/A | N/A |
| Mesa Laboratories, Inc. (MLAB)vs › | $763.75M | 1.99x | 1.56x | 1.53x | 1.63x |
| Ardelyx, Inc. (ARDX)vs › | $800.37M | 1.67x | 3.04x | 3.76x | 3.03x |
| InMode Ltd. (INMD)vs › | $804.32M | 0.57x | 0.81x | 1.35x | 3.44x |
EV/Assets compares enterprise value to total assets. It is useful for asset-heavy businesses and for comparing how much the market pays for each dollar of assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
